Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease.

Tobias JD, Berkenbosch JW
Clin Pediatr (Phila) 2002;41(8):613-616.
NATA Rating :
Review by : Aldouri M
NATA Review
This is a case report on a successful use of recombinant factor VIIa in treating hematemesis in an 11-month-old infant who suffered with esophageal varices, hepatic dysfunction and previous necrotizing enterocolitis. Prior treatment with platelets, FFP and octreotide did not succeed in controlling the bleeding.

– Maadh Aldouri

Consent Management Platform by Real Cookie Banner